ECO Animal Health Group’s (EAH) Buy Rating Reaffirmed at Shore Capital Group

Shore Capital Group reiterated their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note issued to investors on Wednesday, Marketbeat.com reports.

ECO Animal Health Group Trading Up 1.5%

Shares of EAH stock opened at GBX 101 on Wednesday. The company has a current ratio of 3.73, a quick ratio of 2.14 and a debt-to-equity ratio of 5.97. ECO Animal Health Group has a twelve month low of GBX 50 and a twelve month high of GBX 116.90. The company’s 50-day moving average price is GBX 106.04 and its 200-day moving average price is GBX 95.45. The stock has a market cap of £67.76 million, a price-to-earnings ratio of 23.01 and a beta of -0.05.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.